跳至主要内容
临床试验/NCT01317173
NCT01317173Unknown不适用

The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease

Ankara Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
1
主要终点
Progression of kidney disease

研究概览

简要总结

Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-diabetic chronic kidney disease

排除标准

  • Presence of DM
  • Actively using calcium based phosphorus binder of vitamin D

结局指标

主要结局

Progression of kidney disease

时间窗: continuous measurement of kidney functions 3 monthly for two years or until the outcome reached

Doubling of creatinin, requirement of renal replacement therapy

次要结局

  • Evaluation of Ca P metabolism(3 monthly for two years or until the outcome reached)

研究者

发起方
Ankara Education and Research Hospital
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验